ESC Premium Access

Validation of two simple scores to identify increased risk of transthyretin amyloid cardiomyopathy in heart failure with preserved ejection fraction

Congress Presentation

About the speaker

Doctor Mireia Llevadot Sesmilo

Germans Trias and Pujol Hospital, Badalona (Spain)
0 follower

7 more presentations in this session

DPD quantification correlates with ECV and disease severity in patients with ATTR-CM

Speaker: Doctor R. Rettl (Vienna, AT)

Thumbnail

Prognostic significance of right ventricular dysfunction in patients with TTR amyloidosis

Speaker: Doctor S. Istratoaie (Cluj Napoca, RO) Professor E. Donal (Rennes, FR)

Thumbnail

Characterizing the progression of subclinical cardiac amyloidosis through artificial intelligence applied to electrocardiographic images and echocardiograms

Speaker: Doctor E. Oikonomou (New Haven, US)

Thumbnail

Prognostic staging system correctly identifies high risk groups in cardiac transthyretin amyloidosis treated with tafamidis

Speaker: Mr M. Mueller (Berlin, DE)

Thumbnail

Improving early mortality risk detection in light-chain cardiac amyloidosis patients with routine echocardiographic indicators and mayo staging

Speaker: Doctor J. Li (Beijing, CN)

Thumbnail

Access the full session

Cardiac amyloidosis: how to stage and score

Speakers: Doctor M. Llevadot Sesmilo, Doctor R. Rettl, Doctor S. Istratoaie, Professor E. Donal, Doctor E. Oikonomou...
Thumbnail

About the event

Image

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations